P831: PATIENT-REPORTED OUTCOMES IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA TREATED WITH CROVALIMAB: RESULTS FROM THE COMPOSER TRIAL by A. Röth, J. Panse, B. Gentile, M. Buri, H. Patel, Z. Nagy

Get full text

P804: EX VIVO TREATMENT WITH ELTROMBOPAG RESCUES HEMATOPOIETIC STEM CELLS FROM ANTI-THYMOCYTE GLOBULIN-RELATED DAMAGE DURING IMMUNOSUPPRESSIVE THERAPY IN PATIENTS WITH APLASTIC ANE... by M. Vieri, B. Rolles, M. Crocioni, S. Isfort, J. Panse, T. H. Brümmendorf, F. Beier

Get full text

P828: NORMALIZATION OF HEMATOLOGIC AND HEALTH-RELATED QUALITY OF LIFE MARKERS IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA TREATED WITH PEGCETACOPLAN AND BASELINE HEMOGLOBI... by J. Panse, N. Daguindau, S. Okuyama, R. Peffault de Latour, P. Schafhausen, N. Straetmans, M. Al-Adhami, T. Ajayi, E. Persson, M. Yeh, R. Wong

Get full text

RESULTS OF THE PEGASUS PHASE 3 RANDOMIZED TRIAL DEMONSTRATING SUPERIORITY OF THE C3 INHIBITOR PEGCETACOPLAN COMPARED TO ECULIZUMAB IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINU... by H. Weitz, P. Hillmen, J. Szer, A. Röth, B. Höchsmann, J. Panse, K. Usuki, M. Griffin, J. Kiladjian, C. Decastro, H. Nishimori, L. Tan, M. Hamdani, P. Deschatelets, C. Francois, F. Grossi, A. Risitano, R.P. Latour

Get full text

P830: CROVALIMAB MAINTAINS CLINICAL BENEFIT OVER LONG-TERM TREATMENT IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: RESULTS FROM THE COMPOSER TRIAL OPEN-LABEL EXTENSION by A. Röth, M. Egyed, S. Ichikawa, Y. Ito, J. S. Kim, Z. Nagy, N. Obara, J. Panse, H. Schrezenmeier, S. Sica, J. Soret, K. Usuki, S.-S. Yoon, K. Benkali, M. Buri, P. Lundberg, H. Patel, K. Shinomiya, S. Sreckovic, J.-I. Nishimura

Get full text